Abstract
The authors explored whether arecoline, like physostigmine, may worsen depressive symptomatology in depressed patients, and whether arecoline may cause depressive symptomatology in normal volunteers, and whether there are differential mood effects of arecoline in these two groups.
Original language | English |
---|---|
Pages (from-to) | 696-698 |
Number of pages | 3 |
Journal | Psychopharmacology Bulletin |
Volume | 19 |
Issue number | 4 |
State | Published - 1983 |
Externally published | Yes |